Resumo
Stress responses activate protective mechanisms to achieve homeostasis, but they can be detrimental when such responses become maladaptive. Anxiety relates to risk assessment of a potential threat and involves uncertainty regarding the anticipation of a threatening situation and it dampers quality of life. Gamma-Aminobutyric Acid (GABA) is the major inhibitory system in the central nervous system and plays a key role in the regulation of neuronal transmission in the brain, affecting many physiological and psychological processes. This mini-review aims to summarize key points concerned with the GABAergic transmission and basic aspects related to the GABAergic system in anxiety.
Referências
- Atack, J. R. The benzodiazepine binding site of
- GABA(A) receptors as a target for the
- development of novel anxiolytics. Expert
- opinion on investigational drugs, v. 14,
- no. 5, p. 601-618, 2005. https://doi.org/
- 1517/13543784.14.5.601
- Baldwin, D. S.; Allgulander, C.; Altamura, A. C.;
- Angst, J.; Bandelow, B.; den Boer, J.; Boyer, P.;
- Davies, S.; dell’Osso, B.; Eriksson, E.; Fineberg,
- N.; Fredrikson, M.; Herran, A.; Maron, E.;
- Metspalu, A.; Nutt, D.; van der Wee, N.;
- Vázquez-Barquero, J. L.; Zohar, J. Manifesto
- for a European anxiety disorders research
- network. European Neuropsychopharmacology, v. 20, no. 6, p. 426-432, 2010.
- https://doi.org/10.1016/j.euroneuro.
- 02.015
- Baldwin, D. S.; Anderson, I. M.; Nutt, D. J.;
- Bandelow, B.; Bond, A.; Davidson, J. R. T.; Den
- Boer, J. A.; Fineberg, N. A.; Knapp, M.; Scott, J.;
- Wittchen, H. U. Evidence-based guidelines for
- the pharmacological treatment of anxiety
- disorders: Recommendations from the
- British Association for Psychopharmacology.
- Journal of Psychopharmacology, v. 19,
- no. 6, p. 567-596, 2005. https://doi.org/
- 1177/0269881105059253
- Bali, A.; Jaggi, A. S. Clinical experimental
- stress studies: Methods and assessment.
- Reviews in the Neurosciences, v. 26, no. 5,
- p. 555-579, 2015. https://doi.org/10.1515/
- revneuro-2015-0004
- Belda, X.; Fuentes, S.; Daviu, N.; Nadal, R.;
- Armario, A. Stress-induced sensitization: The
- hypothalamic-pituitary-adrenal axis and
- beyond. Stress, v. 18, no. 3, p. 269-279, 2015.
- https://doi.org/10.3109/10253890.2015.10
- Belda, X.; Fuentes, S.; Daviu, N.; Nadal, R.;
- Armario, A. Stress-induced sensitization: The
- hypothalamic-pituitary-adrenal axis and
- beyond. Stress, v. 18, no. 3, p. 269-279, 2015.
- GABAergic transmission and modulation of anxiety 15
- Braz. J. Biol. Sci., 2019, Vol. 6, No. 12, p. 9-16.
- https://doi.org/10.3109/10253890.2015.10
- Beltrán González, A. N.; Pomata, P. E.;
- Goutman, J. D.; Gasulla, J.; Chebib, M.; Calvo,
- D. J. Benzodiazepine modulation of
- homomeric GABAAρ1 receptors: Differential
- effects of diazepam and 4’-chlorodiazepam.
- European Journal of Pharmacology, v. 743,
- p. 24-30, 2014. https://doi.org/10.1016/
- j.ejphar.2014.09.017
- Benarroch, E. E. GABAB receptors: Structure,
- functions, and clinical implications.
- Neurology, v. 78, no. 8, p. 578-584, 2012.
- https://doi.org/10.1212/WNL.0b013e31824
- cd03
- Campbell, E. L., Chebib, M.; Johnston, G. A. R.
- The dietary flavonoids apigenin and (-)-
- epigallocatechin gallate enhance the positive
- modulation by diazepam of the activation by
- GABA of recombinant GABA A receptors.
- Biochemical Pharmacology, v. 68, no. 8,
- p. 1631-1638, 2014. https://doi.org/
- 1016/j.bcp.2004.07.022
- Chebib, M.; Johnston, G. A. R. GABA-activated
- ligand-gated ion channels: Medicinal
- chemistry and molecular biology. Journal of
- Medicinal Chemistry, v. 43, no. 8, p. 1427-
- , 2000. https://doi.org/10.1021/
- jm9904349
- Chebib, M.; Johnston, G. The ‘ABC’ of GABA
- receptors: A brief review. Clinical and
- experimental pharmacology and
- physiology, v. 26, no. 11, p. 937-940, 2004.
- https://doi.org/10.1046/j.1440-1681.
- 03151.x
- Chebib, M.; Hanrahan, J. R.; Mewett, K. N.;
- Duke, R. K.; Johnston, G. A. R. Ionotropic
- GABA receptors as therapeutic targets for
- memory and sleep disorders. Annual
- Reports in Medicinal Chemistry, v. 39,
- no. 4, p. 13-23, 2004. https://doi.org/
- 1016/S0065-7743(04)39002-0
- Chua, H. C.; Chebib, M. GABA receptors and
- the diversity in their structure and
- pharmacology. In: Geraghty, D. P.; Rash, L. D.
- (Eds.). Ion channels downunder. 1. ed.
- Cambridge, MA: Elsevier, 2017. (Advances in
- Pharmacology, v. 79). https://doi.org/
- 1016/bs.apha.2017.03.003
- Cryan, J. F.; Kaupmann, K. Don’t worry “B”
- happy!: A role for GABA receptors in anxiety
- and depression. Trends in Pharmacological
- Sciences, v. 26, no. 1, p. 36-43, 2005.
- https://doi.org/10.1016/j.tips.2004.11.004
- Emson, P. C. GABAB receptors: structure and
- function. Progress in Brain Research,
- v. 160, p. 43-57, 2007. https://doi.org/
- 1016/S0079-6123(06)60004-6
- Fox, A. S.; Kalin, N. H. A Translational
- neuroscience approach to understanding the
- development of social anxiety disorder and
- its pathophysiology. The American Journal
- of Psychiatry, v. 171, no. 11, p. 1162-1173,
- https://doi.org/10.1176/appi.ajp.
- 14040449
- Ghose, S.; Winter, M. K.; McCarson, K. E.;
- Tamminga, C. A.; Enna, S. J. The GABAB
- receptor as a target for antidepressant drug
- action. British Journal of Pharmacology,
- v. 162, no. 11, p. 1-17, 2011.
- https://doi.org/10.1111/j.1476-5381.2010.
- x
- Hasler, G.; Van Der Veen, J. W.; Tumonis, T.;
- Meyers, N.; Shen, J.; Drevets, W. C. Reduced
- prefrontal glutamate/glutamine and γaminobutyric acid levels in major depression
- determined using proton magnetic resonance
- spectroscopy. Archives of General
- Psychiatry, v. 64, no. 2, p. 193-200, 2007.
- https://doi.org/10.1001/archpsyc.64.2.193
- Jacob, T. C.; Moss, S. J.; Jurd, R. GABAA
- receptor trafficking and its role in the
- dynamic modulation of neuronal inhibition.
- Nature Reviews Neuroscience, v. 9, no. 5,
- p. 331-343, 2008. https://doi.org/
- 1038/nrn2370
- Johnston, G. A. R. GABAA receptor
- pharmacology. Pharmacology and
- Therapeutics, v. 69, no. 3, p. 173-198, 1996.
- https://doi.org/10.1016/0163-7258
- (95)02043-8
- Juruena, M. F. Early-life stress and HPA axis
- trigger recurrent adulthood depression.
- Epilepsy and Behavior, v. 38, p. 148-159,
- https://doi.org/10.1016/j.yebeh.2013.
- 020
- Karim, N.; Wellendorph, P.; Absalom, N.;
- Johnston, G. A. R.; Hanrahan, J. R.; Chebib, M.
- Potency of GABA at human recombinant
- GABAA receptors expressed in Xenopus
- oocytes. Amino Acids, v. 44, no. 4, p. 1139-
- , 2013. https://doi.org/10.1007/
- s00726-012-1456-y
- Gomes et al.
- Braz. J. Biol. Sci., 2019, Vol. 6, No. 12, p. 9-16.
- Klumpers, U. M. H.; Veltman, D. J.; Drent, M.
- L.; Boellaard, R.; Comans, E. F. I.; Meynen, G.;
- Lammertsma, A. A.; Hoogendijk, W. J. G.
- Reduced parahippocampal and lateral
- temporal GABAA-[ 11C]flumazenil binding in
- major depression: Preliminary results.
- European Journal of Nuclear Medicine and
- Molecular Imaging, v. 37, no. 3, p. 565-574,
- https://doi.org/10.1007/s00259-009-
- -9
- Kumar, K.; Sharma, S.; Kumar, P.; Deshmukh,
- R. Therapeutic potential of GABAB receptor
- ligands in drug addiction, anxiety, depression
- and other CNS disorders. Pharmacology
- Biochemistry and Behavior, v. 110, p. 174-
- , 2013. https://doi.org/10.1016/j.pbb.
- 07.003
- Li, X.; Risbrough, V. B.; Cates-Gatto, C.;
- Kaczanowska, K.; Finn, M. G.; Roberts, A. J.;
- Markou, A. Neuropharmacology comparison
- of the effects of the GABA B receptor positive
- modulator BHF177 and the GABA B receptor
- agonist baclofen on anxiety-like behavior,
- learning, and memory in mice.
- Neuropharmacology, v. 70, p. 156-167,
- https://doi.org/10.1016/j.neuropharm
- .2013.01.018
- Möhler, H. The GABA system in anxiety and
- depression and its therapeutic potential.
- Neuropharmacology, v. 62, no. 1, p. 42-53,
- https://doi.org/10.1016/j.neuropharm
- .2011.08.040
- Mombereau, C.; Kaupmann, K.; Gassmann, M.;
- Bettler, B.; Van Der Putten, H.; Cryan, J. F.
- Altered anxiety and depression-related
- behavior in mice lacking GABA B(2) receptor
- subunits. NeuroReport, v. 16, no. 3, p. 307-
- , 2005.
- Rajkowska, G.; Miguel-Hidalgo, J. J.; Wei, J.;
- Dilley, G.; Pittman, S. D.; Meltzer, H. Y.;
- Overholser, J. C.; Roth, B. L.; Stockmeier, C. A.
- Morphometric evidence for neuronal and
- glial prefrontal cell pathology in major
- depression. Biological Psychiatry, v. 45,
- no. 9, p. 1085-1098, 1999. https://doi.org/
- 1016/S0006-3223(99)00041-4
- Rajkowska, G.; O’Dwyer, G.; Teleki, Z.;
- Stockmeier, C. A.; Miguel-Hidalgo, J. J.
- GABAergic neurons immunoreactive for
- calcium binding proteins are reduced in the
- prefrontal cortex in major depression.
- Neuropsychopharmacology, v. 32, no. 2,
- p. 471-482, 2007. https://doi.org/10.1038/
- sj.npp.1301234
- Réus, G. Z.; Santos, M. A. B.; Abelaira, H. M.;
- Quevedo, J. Animal models of social anxiety
- disorder and their validity criteria. Life
- Sciences, v. 114, no. 1, p. 1-3, 2014.
- https://doi.org/10.1016/j.lfs.2014.08.002
- Rudolph, U.; Mohler, H. GABA-based
- therapeutic approaches: GABAA receptor
- subtype functions. Current Opinion in
- Pharmacology, v. 6, no. 1, p. 18-23, 2006.
- https://doi.org/10.1016/j.coph.2005.10.003
- Sanacora, G.; Mason, G. F.; Rothman, D. L.;
- Behar, K. L.; Hyder, F.; Petroff, O. A.; Berman,
- R. M., Charney, D. S.; Krystal, J. H. Reduced
- cortical gamma-aminobutyric acid levels in
- depressed patients determined by proton
- magnetic resonance spectroscopy. Archives
- of general psychiatry, v. 56, no. 11, p. 1043-
- , 1999. https://doi.org/10.1001/
- archpsyc.56.11.1043
- Sieghart, W. Structure, pharmacology, and
- function of GABAA receptor subtypes.
- Advances in Pharmacology, v. 54, no. 6,
- p. 231-263, 2006. https://doi.org/10.1016/
- S1054-3589(06)54010-4
- Sinkkonen, S. T.; Hanna, M. C.; Kirkness, E. F.;
- Korpi, E. R. GABA(A) receptor epsilon and
- theta subunits display unusual structural
- variation between species and are enriched
- in the rat locus ceruleus. The Journal of
- Neuroscience, v. 20, no. 10, p. 3588-3595,
- https://doi.org/10.1523/jneurosci.20-
- -03588.2000
- Stein, M. B.; Sareen, J. Generalized Anxiety
- Disorder. New England Journal of
- Medicine, v. 373, no. 21, p. 2059-2068, 2015.
- https://doi.org/10.1056/NEJMcp1502514
- Varani, A. P.; Pedrón, V. T.; Machado, L. M.;
- Antonelli, M. C.; Bettler, B.; Balerio, G. N. Lack
- of GABA B receptors modifies behavioral and
- biochemical alterations induced by
- precipitated nicotine withdrawal.
- Neuropharmacology, v. 90, p. 90-101, 2015.
- https://
